News Conference News ESC 2023 MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization Michael O'Riordan August 28, 2023
News Daily News Women and Minorities Underrepresented in Heart Valve Trials L.A. McKeown July 27, 2023
News Conference News ESC Heart Failure 2023 Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues Shelley Wood May 25, 2023
News Daily News Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials Todd Neale May 04, 2023
News Daily News Radiation Exposure Highest for Interventional Imagers at Right Waist and Below Yael L. Maxwell March 29, 2023
News Daily News SCAI Updates Position on Doing PCI Without Surgical Backup Michael O'Riordan February 20, 2023
News Conference News ISET 2023 Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine Caitlin E. Cox January 26, 2023
News Conference News ISET 2023 As Outpatient Facilities Proliferate, So Too Does Scrutiny Caitlin E. Cox January 17, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
News Daily News CMR Could Refine Early Management Decisions in Aortic Regurgitation L.A. McKeown July 27, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News Statins Underprescribed in PAD Before and After Interventions L.A. McKeown December 03, 2021
News Daily News CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky Michael O'Riordan September 10, 2021
News Opinion Off Script Behind Every Tweet, a Person: Firsthand Lessons in Twitter Decorum Nishat Siddiqi July 15, 2021
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021